Growth Hormone Treatment Improves Cognitive Function in Short Children with Growth Hormone Deficiency

Growth Hormone Treatment Improves Cognitive Function in Short Children with Growth Hormone Deficiency
复制标题

DOI:
10.1159/000375529
复制
发表时间:
2015-01-01
影响因子:
3.2
通讯作者:
Albertsson-Wikland, Kerstin
Albertsson-Wikland, Kerstin
中科院分区:
医学3区
文献类型:
--
作者:
Chaplin, John Eric;Kristrom, Berit;Albertsson-Wikland, Kerstin

文献摘要

被引文献

相似文献

背景/目标:我们调查了认知和生长激素(GH)的状态和GH治疗的短青春期前儿童广泛的GH分泌之间的关联。研究方法:共有99名儿童(年龄3-11岁),41名GH缺乏症(GHD)和58名特发性身材矮小症(ISS),被随机分配至固定剂量(43 μ g/kg/天)或预测模型指导的个体化剂量(17-100 μ g/kg/天),并随访24个月。在一项纵向和混合的受试者内和受试者之间的研究中,我们研究了临床效应量的变化,通过科恩d测量,在全面智商(FSIQ)和二级智商指数。结果如下:在GH缺乏组中,FSIQ(p = 0.001,Cohen’s d = 0.63)、操作智商(p = 0.001,Cohen’s d = 0.65)和处理速度(p = 0.005,Cohen’s d = 0.71)的中等效应量显著增加。相比之下,感知组织仅在ISS组中增加(p = 0.001,Cohen's d = 0.53)。基线IQ呈正态分布,两组间差异较小但显著:GH缺乏儿童FSIQ较低(p = 0.042),操作IQ较低(p = 0.021)。使用多元回归分析,基线时GH(max)和IGF-I-SDS解释了Delta处理速度评分(0-24个月)中40%的方差。结论:生长激素缺乏儿童的智商,特别是液体智力增加。GH/IGF-I轴的治疗前状态对这些变化具有显著的预测作用。(C)2015 S. Karger AG,巴塞尔
Background/Aims: We investigated the association between cognition and growth hormone (GH) status and GH treatment in short prepubertal children with broadly ranging GH secretion. Methods: A total of 99 children (age 3-11 years), 41 with GH deficiency (GHD) and 58 with idiopathic short stature (ISS), were randomized to a fixed dose (43 mu g/kg/day) or a prediction model-guided individualized dose (17-100 mu g/kg/day) and followed up for 24 months. In a longitudinal and mixed within-and between-subjects study, we examined clinical effect size changes, measured by Cohen's d, in full-scale IQ (FSIQ) and secondary IQ indices. Results: Significant increases giving medium effect size in FSIQ (p = 0.001, Cohen's d = 0.63), performance IQ (p = 0.001, Cohen's d = 0.65) and processing speed (p = 0.005, Cohen's d = 0.71) were found in the GH-deficient group. In contrast, perceptual organization only increased in the ISS group (p = 0.001, Cohen's d = 0.53). Baseline IQ was normally distributed with small but significant differences between the groups: GH-deficient children had lower FSIQ (p = 0.042) and lower performance IQ (p = 0.021). Using multiple regression analysis, 40% of the variance in delta processing speed scores (0-24 months) was explained by GH(max) and IGF-I-SDS at baseline. Conclusion: IQ, specifically fluid intelligence, increased in the GH-deficient children. The pretreatment status of the GH/IGF-I axis was significantly predictive for these changes. (C) 2015 S. Karger AG, Basel